Hazardous Use of Benzodiazepine and Z-Drugs in Psychiatric Clinics in China: An Electronic Prescription Database Study
Xiaomin Xu,Jiajun Xu,Chuanwei Li,Gang Wang,Wenzhe Wang,Yujian Ye,Yong Chen,Tieqiao Liu,Min Zhao,Xuyi Wang,Na Zhong,Haifeng Jiang
DOI: https://doi.org/10.2139/ssrn.3949409
2021-01-01
Abstract:Background: Benzodiazepines (BZDs) and Z-drugs have been widely used in clinical practice and there have been limited data from large populations about hazardous BZDs and Z-drugs use and its correlates in patients with mental disorder. The study aimed to assess the current status of hazardous BZDs and Z-drugs use and its related factors via analysis of prescriptions in outpatient psychiatric settings in China.Methods: The study included outpatients who were prescribed at least one BZDs or Z-drugs from 5 psychiatric settings in the east, central and west regions of China in 2018. Demographic and prescription information were extracted from the electronic prescription dispensing database. We defined the co-occurence of overdose [>40mg Diazepam Milligram Equivalence (DME)] and long-term use (>consecutive 90 days) as the hazardous hypnotics use, and patients whose recorded diagnoses did not meet any indications in Chinese FDA as the over-indication users. In addition, 200 patients who were detected as hazardous users in one of the hospitals in the east region were randomly selected for follow-up interview to confirm the actual situation.Findings: Among the 720 054 outpatients in 2018, 164 450 (22·8%) patients had at least one BZDs or Z-drugs prescription. Most of the patients were females (63·6%) and were aged 18 to 64 (76·2%). Of the total patients, 55·9% patients were prescribed with over-indication use and 3% were defined as hazardous users. Multivariate logistic regression shown that factors associated with a greater likelihood of hazardous use were older age (aOR[>65]: 5·05; 95%CI: 3·24-8·40), male gender (aOR: 1·20; 95%CI: 1·13-1·28), west region (aOR 1·13; 95%CI: 1·05-1·22), over-indications use (aOR 3·09; 95%CI: 2·82-3·39), a more frequent outpatient visit (aOR 1·06; 95%CI: 1·06-1·07), a greater number of different doctors visits (aOR 1·23; 95%CI: 1·22-1·24), and patients diagnosed particularly as Behavioral syndromes associated with physiological disturbances and physical factors (aOR 3·65; 95%CI:3·07-4·30), Epilepsy and recurrent seizures (aOR 5·22; 95%CI: 4·29-6·30) and Sleep disorders (aOR 1·85; 95%CI: 1·67-2·04). 98·5% (197/200) of patients at hazardous use risk cannot be effectively accessed because they registered the wrong contact information in the outpatient system (72·5%) or refused to be followed up (26%), and one of three patients who completed the interview met the DSM-5 criteria for Sedative hypnotics dependence syndrome.Interpretation: Sedative hypnotic drugs are commonly used clinically, and there are relatively large proportion of over-indication users in outpatients psychiatric settings in China. Whereas, a small proportion of patients at risk of hazardous BZDs and Z-drugs use (long-term and high-dose use) were detected by prescription data. The question raised by this study is how to use prescription data to support improvements in clinical practice.Funding: National Natural Science Foundation of China, Clinical Research Center of Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center Clinical Research Center and Shanghai Municipal Health Commission.Declaration of Interest: None to declare. Ethical Approval: The study was approved and monitored by Shanghai Mental Health Center (permission number: 2019-22)